Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Owens & Minor, Inc. Common Stock (NY:OMI)

4.800 +0.210 (+4.58%)
Official Closing Price Updated: 7:00 PM EDT, Oct 17, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Owens & Minor, Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
1 Healthcare Stock on Our Buy List and 2 to Ignore
Personal health and wellness is one of the many secular tailwinds for healthcare companies. But financial performance has lagged recently as players offloaded surplus COVID inventories in 2023 and... 
Via StockStory
Topics Stocks
Hello Group, loanDepot, Mineralys Therapeutics And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
 
Via Benzinga
Demystifying Owens & Minor: Insights From 5 Analyst Reviews
 
Via Benzinga
Keep an eye on the top gainers and losers in Friday's session.
Keep an eye on the top gainers and losers in Friday's session, as they reflect the most notable price movements. 
Via Chartmill
Analyst Ratings For Owens & Minor
 
Via Benzinga
Owens & Minor (OMI) Shares Skyrocket, What You Need To Know
Shares of medical supply and logistics company Owens & Minor (NYSE:OMI) jumped 36.9% in the afternoon session after the company reported impressive fourth quarter 2024 results, exceeding analysts'... 
Via StockStory
Friday's session: top gainers and losers
Wondering how the US markets performed in the middle of the day on Friday? Discover the movers and shakers of today's session in our comprehensive analysis. 
Via Chartmill
These stocks are gapping in today's session
There are notable gap-ups and gap-downs in today's session. Let's take a look at which stocks are gapping on Friday. 
Via Chartmill
Healthcare Logistics Firm Owens & Minor Reports Better-Than-Expected Q4 Earnings, Plans To Repurchase $100 Million In Shares
Owens & Minor beat Q4 EPS and revenue estimates, announced a $100M buyback, and provided 2025 guidance, projecting double-digit adjusted EBITDA growth. 
Via Benzinga
Owens & Minor (NYSE:OMI) Reports Q4 In Line With Expectations
Medical supply and logistics company Owens & Minor (NYSE:OMI) met Wall Street’s revenue expectations in Q4 CY2024, with sales up 1.5% year on year to $2.70 billion. The company’s outlook for the full... 
Via StockStory
Topics Economy
Owens & Minor Reports Fourth Quarter & Full Year Financial Results and Announces Sale Process Underway for Products & Healthcare Services Segment
From Owens & Minor, Inc.
Via Business Wire
US Stocks Likely To Open Higher Following A Sell-Off, 'This Choppy Start To 2025 Isn't Abnormal. Don't Panic,' Says Expert Highlighting Seasonal Weakness In The First Quarter After Elections
U.S. stock futures rose on Friday following Thursday's sell-off. Futures advanced except the small-cap gauge Russell 2000. 
Via Benzinga
Earnings Scheduled For February 28, 2025
 
Via Benzinga
Nasdaq Tumbles Over 500 Points As Nvidia Plunges Post Q4 Results: Investor Sentiment Declines Further, Greed Index Remains In 'Extreme Fear' Zone
 
Via Benzinga
HP, Dell Technologies And 3 Stocks To Watch Heading Into Friday
 
Via Benzinga
Owens & Minor (OMI) Reports Q4: Everything You Need To Know Ahead Of Earnings
Medical supply and logistics company Owens & Minor (NYSE:OMI) will be reporting earnings tomorrow morning. Here’s what to expect. 
Via StockStory
3 Reasons to Sell OMI and 1 Stock to Buy Instead
Shareholders of Owens & Minor would probably like to forget the past six months even happened. The stock has dropped 49.9% and now trades at a new 52-week low of $7.77. This was partly driven by its... 
Via StockStory
Owens & Minor Launches ByramConnect Digital Health Platform for Diabetes and Other Chronic Health Conditions
From Owens & Minor
Via Business Wire
US Stocks Likely To Open Lower As Trump's Trade War Continues To Impact The Market: 'Volatility Is The Toll We Pay To Invest,' Says Expert
U.S. stock futures were trading lower on Tuesday after Monday's decline as the new administration tariffs continued to spook the market. 
Via Benzinga
Topics Government World Trade
Dow Trims Losses After Trump Delays Mexico, Canada Tariffs: Greed Index Remains In 'Fear' Zone
 
Via Benzinga
Topics Government Stocks
Top movers in Monday's session
Keep an eye on the top gainers and losers in Monday's session, as they reflect the most notable price movements. 
Via Chartmill
Crude Oil Moves Higher; Owens & Minor Shares Plummet
 
Via Benzinga
Keep an eye on the top gainers and losers in Monday's session.
Let's have a look at what is happening on the US markets in the middle of the day on Monday. Below you can find the top gainers and losers in today's session. 
Via Chartmill
Dow Falls 150 Points; ISM Manufacturing PMI Rises In January
 
Via Benzinga
Topics Stocks
Stocks Pare Losses After Trump Pauses Mexico Tariffs
Stocks are lower midday, but have pared much steeper premarket losses, after U.S. President Trump paused tariffs on Mexico for one month. 
Via Talk Markets
Topics Government Stocks / Equities World Trade
Owens & Minor Stock Dips On Mixed Q4 Preliminary Results & $310 Million Apria Goodwill Charge: Details
Owens & Minor shares dipped after disclosing preliminary results and financing for the Rotech Healthcare Holdings, Inc. buyout. The company expects to close the deal in the first half of 2025 and sees... 
Via Benzinga
Owens & Minor Launches Financing for Rotech Acquisition and Provides Preliminary Fourth Quarter and Full Year 2024 Financial Results Ahead of Investor Meetings
From Owens & Minor, Inc.
Via Business Wire
Owens & Minor to Present at Upcoming Investor Conferences
From Owens & Minor
Via Business Wire
Charter Communications To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Tuesday
 
Via Benzinga
Health Solutions Provider Owens & Minor's Q3 Earnings: Revenue And EPS Beat, Trims Annual Outlook
Owens & Minor Q3 2024 highlights include a 5% sales increase to $2.72 billion, adjusted EPS of $0.42, and Patient Direct revenue growth led by diabetes and sleep supplies. 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.